Carotid Artery Corrected Flow Time and Inferior Vena Cava Collapsibility Index for Prediction of Hypotension After Induction of General Anesthesia in Geriatric Patients Undergoing Elective Surgery
Launched by TANTA UNIVERSITY · Feb 3, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain measurements can help predict low blood pressure (hypotension) in older patients after they receive general anesthesia for elective surgery. Specifically, the researchers will use two methods: an ultrasound of the carotid artery and a measurement called the inferior vena cava (IVC) collapsibility index. These tests aim to understand better which patients might be at risk of experiencing low blood pressure after they are sedated for surgery.
To be eligible for this study, participants need to be older adults (typically aged 65 and above) who are healthy enough for surgery, as defined by specific criteria. They should not have certain health problems, such as severe heart or lung issues, significant obesity, or a history of difficult intubation (which is inserting a tube to help with breathing during surgery). If chosen to participate, individuals will undergo the ultrasound and other assessments before their surgery to help ensure their safety during the procedure. This study is not yet recruiting participants, but it aims to improve care for older patients undergoing surgery in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • American Society of Anaesthesiologists Physical Status I to Ⅱ
- • receiving general anesthesia for elective surgery
- • fasted for at least 6 to 8 hours were recruited in this study
- Exclusion Criteria:
- • • patients who refused to participate in the study
- • American Society of Anaesthesiologists Physical Status Ⅲ or Ⅳ
- • Patients with a history of peripheral arterial diseases or atherosclerosis
- • Patients with body mass index of greater than 30 kg/m2
- • Patients with arrhythmia or cardiomyopathy
- • Chronic obstructive pulmonary disease (COPD)
- • baseline systolic arterial pressure (SAP) ≥ 180 mmHg or \< 90mmHg
- • Any episode of desaturation or difficult intubation during general anasethia induction
About Tanta University
Tanta University is a prestigious academic institution located in Egypt, dedicated to advancing medical research and education. As a clinical trial sponsor, Tanta University leverages its extensive resources and expertise to conduct innovative research initiatives aimed at improving health outcomes. The university collaborates with a network of healthcare professionals, researchers, and institutions to facilitate rigorous clinical trials across various medical disciplines. Committed to ethical standards and scientific integrity, Tanta University strives to contribute to the global body of knowledge while fostering the next generation of medical professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
tarek Mostafa
Principal Investigator
tanta university, faculty of medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported